Personalized Medicine Is Closer Than You Think, FDA’s Throckmorton Says

Personalized medicine should be adopted as a prospective strategy in drug development rather than primarily serving as a tool to salvage failing drug candidates, participants at FDA's Science Forum suggested

More from Archive

More from Pink Sheet